Dejerine-Sottas Disease (disorder)
|
0.940 |
Biomarker
|
disease |
BEFREE |
EGR2 mutations typically cause different forms of demyelinating neuropathy, that is, Charcot-Marie-Tooth type 1D (CMT1D), Dejerine-Sottas Syndrome (DSS), and Congenital Hypomyelinating Neuropathy (CHN).
|
30843326 |
2019 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
Biomarker
|
disease |
MGD |
Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation.
|
19244508 |
2009 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
Biomarker
|
disease |
MGD |
Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination.
|
15695336 |
2005 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
Biomarker
|
disease |
MGD |
Nab proteins are essential for peripheral nervous system myelination.
|
16136673 |
2005 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
GermlineCausalMutation
|
disease |
ORPHANET |
Furthermore, in contrast to patients with typical DSN, patients with the EGR2 R359W mutation have more respiratory compromise and cranial nerve involvement.
|
11523566 |
2001 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy.
|
11523566 |
2001 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
A de novo missense mutation (Arg359Trp) in the alpha-helix of the first zinc-finger domain of the EGR2 transcription factor was identified in a patient diagnosed with a clinical phenotype consistent with DSS.
|
10371530 |
1999 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
Mutations in three genes coding for the myelin proteins peripheral myelin protein 22, myelin protein zero and connexin 32 and in one gene coding for the transcription factor early growth response 2 element are associated with Charcot-Marie-Tooth type 1 and 2, hereditary neuropathy with liability to pressure palsies, Dejerine-Sottas syndrome and congenital hypomyelination.
|
10541586 |
1999 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
GeneticVariation
|
disease |
UNIPROT |
A de novo missense mutation (Arg359Trp) in the alpha-helix of the first zinc-finger domain of the EGR2 transcription factor was identified in a patient diagnosed with a clinical phenotype consistent with DSS.
|
10371530 |
1999 |
Dejerine-Sottas Disease (disorder)
|
0.940 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Dejerine-Sottas Disease (disorder)
|
0.940 |
Biomarker
|
disease |
CTD_human |
|
|
|
Dejerine-Sottas Disease (disorder)
|
0.940 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Dejerine-Sottas Disease (disorder)
|
0.940 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Homozygous deletion of an EGR2 enhancer in congenital amyelinating neuropathy.
|
22522483 |
2012 |
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
Biomarker
|
disease |
MGD |
Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation.
|
19244508 |
2009 |
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
Biomarker
|
disease |
MGD |
Nab proteins are essential for peripheral nervous system myelination.
|
16136673 |
2005 |
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
Biomarker
|
disease |
MGD |
Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination.
|
15695336 |
2005 |
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies.
|
9537424 |
1998 |
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Charcot-Marie-Tooth disease, Type 1D (disorder)
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Mutations of EGR2 have been found in patients with congenital hypomyelinating neuropathy or Charcot-Marie-Tooth disease type 1D.
|
22522483 |
2012 |
Charcot-Marie-Tooth disease, Type 1D (disorder)
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot-Marie-Tooth disease family.
|
15947997 |
2005 |
Charcot-Marie-Tooth disease, Type 1D (disorder)
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.
|
15241803 |
2004 |